Marazzi Fabio, Masiello Valeria, Franceschini Gianluca, Bosello Silvia, Moschella Francesca, Smaniotto Daniela, Luzi Stefano, Mulé Antonino, Gambacorta Maria Antonietta, Gremese Elisa, Masetti Riccardo, Valentini Vincenzo
Fondazione Policlinico Universitario "A. Gemelli" IRCCS, UOC di Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Roma, Italy.
Fondazione Policlinico Universitario "A. Gemelli" IRCCS, UOC di Chirurgia Senologica, Dipartimento di Scienze della Salute della Donna e del Bambino e di Sanità Pubblica, Roma, Italy.
Rep Pract Oncol Radiother. 2020 Jul-Aug;25(4):527-532. doi: 10.1016/j.rpor.2020.03.013. Epub 2020 May 22.
This manuscript focuses on the first experience in literature of a patient with a complicated Adult Onset Still's Disease-related heart failure who thereafter underwent adjuvant radiotherapy for left breast cancer.
AOSD is a rare autoimmune inflammation-related disease, in which life-threatening pulmonary and cardiac complications can occur. In literature, AOSD is often associated with cancer, as paraneoplastic syndrome, but there are few data about primary AOSD and management of oncological therapies.
A patient who needed adjuvant breast cancer radiotherapy underwent tumour board evaluation to define feasibility of an RT in a patient with of a history of a heart life-threatening complication 2 years before AOSD. Results of the review were discussed by a multidisciplinary panel of experts that chose the type of surgery, radiotherapy and monitoring of patient.
Literature review confirmed association of AOSD with BC in some pts and uniqueness of this treatment management experience. Patient underwent RT according to schedule of 40.05/2.67 Gy/fx on residual left breast and 10/2 Gy/fx on tumour bed with the gating technique. The panel chose to keep immunosuppressive therapy with anakinra. No complications were observed at clinical, ECG and laboratory examinations. Maximum toxicity was G2 skin. At first follow up AOSD signs of flare were negative.
In conclusion, when oncological treatments, especially radiotherapy, are mandatory for AOSD pts, multidisciplinary management and tailored monitoring are necessary to avoid acute adverse effects and allow pts to complete therapies.
本手稿聚焦于文献中首例患有复杂成人斯蒂尔病相关心力衰竭的患者,该患者随后接受了左乳腺癌辅助放疗。
成人斯蒂尔病(AOSD)是一种罕见的自身免疫性炎症相关疾病,可发生危及生命的肺部和心脏并发症。在文献中,AOSD常与癌症相关,作为副肿瘤综合征,但关于原发性AOSD及肿瘤治疗管理的数据较少。
一名需要进行乳腺癌辅助放疗的患者接受了肿瘤多学科会诊评估,以确定在AOSD发病前2年有危及生命的心脏并发症病史的患者进行放疗的可行性。多学科专家小组讨论了会诊结果,选择了手术类型、放疗方式及患者监测方案。
文献综述证实了部分患者中AOSD与乳腺癌(BC)的关联以及这种治疗管理经验的独特性。患者按照计划对左侧残留乳腺采用40.05/2.67 Gy/分次进行放疗,对瘤床采用10/2 Gy/分次并使用门控技术。专家小组选择继续使用阿那白滞素进行免疫抑制治疗。临床、心电图和实验室检查均未观察到并发症。最大毒性为2级皮肤毒性。首次随访时,AOSD复发迹象为阴性。
总之,当AOSD患者必须接受肿瘤治疗,尤其是放疗时,多学科管理和针对性监测对于避免急性不良反应及使患者完成治疗是必要的。